Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICON-TBI: Neuroinflammatory Biomarkers in Severe TBI
NCT03659006Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2018
- Primary completion
- Jul 2020
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Interleukin-1 level at 12 months. Status: unknown.
Beyond the preview
Go deeper on NCT03659006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03659006.